Product Information
PROVIGIL 200 MG TABLET is a brand product labeled by Cephalon, LLC, priced at $80.3260 per EA under NDC 63459020130. Its NADAC has been published 648 times since Nov 28, 2013.
FDA first approved this application on Dec 24, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Modafinil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Cephalon, LLCNDC
63459020130
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MODAFINILApproval Type
New Drug (NDA)
FDA Application
NDA020717FDA Approved
12/24/1998
TE Code
AB
On Market Since
2/15/1999
Pharmacological Classes
Price Statistics
The NADAC for PROVIGIL 200 MG TABLET has been published 648 times since Nov 28, 2013, and over the history we have for it it has risen 125.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $80.3260 per EA |
|---|---|
| All-time high | $80.9374 (Jun 11, 2025) |
| All-time low | $35.6180 (Nov 28, 2013) |
| 52-week high | $80.5853 |
| 52-week low | $80.2569 |
| Median price | $57.1945 |
| Average price | $56.7533 |
| Largest weekly change | +9.4% (Jul 11, 2018) |
| Weeks tracked | 648 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROVIGIL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROVIGIL 200 MG TABLET, manufactured by Cephalon, LLC, is $80.3260 per EA (NDC 63459020130), effective Aug 19, 2026.
How has the price of PROVIGIL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROVIGIL 200 MG TABLET has risen 125.5%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROVIGIL 200 MG TABLET?
Since Nov 28, 2013, the NADAC for PROVIGIL 200 MG TABLET has ranged from a low of $35.6180 (Nov 28, 2013) to a high of $80.9374 (Jun 11, 2025), with a median of $57.1945 per EA.
Are there cheaper alternatives to PROVIGIL 200 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MODAFINIL 200 MG TABLET, is $0.3483 per EA — about 99% below PROVIGIL 200 MG TABLET.
Who manufactures PROVIGIL 200 MG TABLET?
PROVIGIL 200 MG TABLET (NDC 63459020130) is labeled by Cephalon, LLC, and CMS classifies it as a brand product.